LAVA Therapeutics N.V. (LVTX)

LAVA Therapeutics Statistics

Total Valuation

LVTX has a market cap or net worth of $27.09 million. The enterprise value is -$45.51 million.

Market Cap	27.09M
Enterprise Value	-45.51M

Important Dates

The last earnings date was Tuesday, December 10, 2024, before market open.

Earnings Date	Dec 10, 2024
Ex-Dividend Date	n/a

Share Statistics

LVTX has 26.30 million shares outstanding. The number of shares has increased by 3.18% in one year.

Current Share Class	26.30M
Shares Outstanding	26.30M
Shares Change (YoY)	+3.18%
Shares Change (QoQ)	+0.09%
Owned by Insiders (%)	0.77%
Owned by Institutions (%)	6.43%
Float	12.09M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	3.80
Forward PS	n/a
PB Ratio	0.82
P/TBV Ratio	0.82
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 5.36, with a Debt / Equity ratio of 0.19.

Current Ratio	5.36
Quick Ratio	5.26
Debt / Equity	0.19
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -63.12% and return on invested capital (ROIC) is -35.02%.

Return on Equity (ROE)	-63.12%
Return on Assets (ROA)	-18.03%
Return on Capital (ROIC)	-35.02%
Revenue Per Employee	$198,514
Profits Per Employee	-$747,081
Employee Count	37
Asset Turnover	0.08
Inventory Turnover	n/a

Taxes

In the past 12 months, LVTX has paid $311,000 in taxes.

Income Tax	311,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -31.79% in the last 52 weeks. The beta is 0.42, so LVTX's price volatility has been lower than the market average.

Beta (5Y)	0.42
52-Week Price Change	-31.79%
50-Day Moving Average	1.63
200-Day Moving Average	2.12
Relative Strength Index (RSI)	32.45
Average Volume (20 Days)	172,496

Short Selling Information

The latest short interest is 21,060, so 0.08% of the outstanding shares have been sold short.

Short Interest	21,060
Short Previous Month	26,439
Short % of Shares Out	0.08%
Short % of Float	0.17%
Short Ratio (days to cover)	0.41

Income Statement

In the last 12 months, LVTX had revenue of $7.35 million and -$27.64 million in losses. Loss per share was -$1.02.

Revenue	7.35M
Gross Profit	7.19M
Operating Income	-28.04M
Pretax Income	-28.31M
Net Income	-27.64M
EBITDA	-27.48M
EBIT	-28.04M
Loss Per Share	-$1.02

Balance Sheet

The company has $78.88 million in cash and $6.29 million in debt, giving a net cash position of $72.59 million or $2.76 per share.

Cash & Cash Equivalents	78.88M
Total Debt	6.29M
Net Cash	72.59M
Net Cash Per Share	$2.76
Equity (Book Value)	32.99M
Book Value Per Share	1.25
Working Capital	66.34M

Cash Flow

In the last 12 months, operating cash flow was -$28.60 million and capital expenditures -$23,000, giving a free cash flow of -$28.63 million.

Operating Cash Flow	-28.60M
Capital Expenditures	-23,000
Free Cash Flow	-28.63M
FCF Per Share	-$1.09

Margins

Gross Margin	97.90%
Operating Margin	-381.74%
Pretax Margin	-372.10%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

LVTX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-3.18%
Shareholder Yield	-3.18%
Earnings Yield	-102.05%
FCF Yield	-105.68%

Analyst Forecast

The average price target for LVTX is $3.33, which is 223.30% higher than the current price. The consensus rating is "Buy".

Price Target	$3.33
Price Target Difference	223.30%
Analyst Consensus	Buy
Analyst Count	3
Revenue Growth Forecast (5Y)	56.23%
EPS Growth Forecast (5Y)	-21.54%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

LVTX has an Altman Z-Score of -2.27 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-2.27
Piotroski F-Score	3